Cargando…
Anti-Islet Autoantibodies in Type 1 Diabetes
Anti-islet autoantibodies serve as key markers in immune-mediated type 1 diabetes (T1D) and slowly progressive T1D (SPIDDM), also known as latent autoimmune diabetes in adults (LADA). Autoantibodies to insulin (IAA), glutamic acid decarboxylase (GADA), tyrosine phosphatase-like protein IA-2 (IA-2A),...
Autor principal: | Kawasaki, Eiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298549/ https://www.ncbi.nlm.nih.gov/pubmed/37373160 http://dx.doi.org/10.3390/ijms241210012 |
Ejemplares similares
-
Prevalence of Islet Autoantibodies in Type 1 Diabetes
por: Dayal, Devi, et al.
Publicado: (2017) -
Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1
por: Orban, Tihamer, et al.
Publicado: (2009) -
Autoantibodies against islet cell antigens in children with type 1 diabetes mellitus
por: Cheng, Bi-Wen, et al.
Publicado: (2018) -
Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children
por: Ng, Kenney, et al.
Publicado: (2022) -
Shared Genetic Basis for Type 1 Diabetes, Islet Autoantibodies, and Autoantibodies Associated With Other Immune-Mediated Diseases in Families With Type 1 Diabetes
por: Brorsson, Caroline A., et al.
Publicado: (2015)